China’s Clover Biopharmaceuticals is set to debut on the Stock Exchange of Hong Kong on Friday as it races to win regulatory approval and begin shipments of its Covid-19 vaccine. Though founded in …
( read original story …)
The HongKong News
China’s Clover Biopharmaceuticals is set to debut on the Stock Exchange of Hong Kong on Friday as it races to win regulatory approval and begin shipments of its Covid-19 vaccine. Though founded in …
( read original story …)